"Inactive" excipients such as Cremophor can affect in vivo drug disposition

被引:56
作者
Wandel, C
Kim, RB
Stein, CM
机构
[1] Vanderbilt Univ, Sch Med, Dept Med, Div Clin Pharmacol, Nashville, TN 37212 USA
[2] Hoffmann La Roche AG, Basel, Switzerland
关键词
CASTOR-OIL; ABSORPTION; EL; PACLITAXEL; DECREASES; MECHANISM; DIGOXIN; LIMITS;
D O I
10.1016/S0009-9236(03)00010-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:394 / 396
页数:3
相关论文
共 19 条
[1]   GRAPEFRUIT JUICE FELODIPINE INTERACTION - MECHANISM, PREDICTABILITY, AND EFFECT OF NARINGIN [J].
BAILEY, DG ;
ARNOLD, JMO ;
MUNOZ, C ;
SPENCE, JD .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (06) :637-642
[2]   Pharmaceutical excipient development: The need for preclinical guidance [J].
Baldrick, P .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2000, 32 (02) :210-218
[3]   Entrapment by Cremophor EL decreases the absorption of paclitaxel from the gut [J].
Bardelmeijer, HA ;
Ouwehand, M ;
Malingré, MM ;
Schellens, JHM ;
Beijnen, JH ;
van Tellingen, O .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 49 (02) :119-125
[4]   MECHANISM OF INHIBITORY EFFECT OF PAS GRANULES ON ABSORPTION OF RIFAMPICIN - ADSORPTION OF RIFAMPICIN BY AN EXCIPIENT, BENTONITE [J].
BOMAN, G ;
LUNDGREN, P ;
STJERNSTROM, G .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 8 (05) :293-299
[5]   The effect of water-soluble vitamin E On cyclosporine pharmacokinetics in healthy volunteers [J].
Chang, T ;
Benet, LZ ;
Hebert, MF .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (03) :297-303
[6]  
Cornaire G, 2000, ARZNEIMITTEL-FORSCH, V50, P576
[7]   Dietary salt increases first-pass elimination of oral quinidine [J].
Darbar, D ;
DellOrto, S ;
Morike, K ;
Wilkinson, GR ;
Roden, DM .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (03) :292-300
[8]   Evaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivo [J].
Dresser, GK ;
Wacher, V ;
Wong, S ;
Wong, HT ;
Bailey, DG .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (03) :247-255
[9]   Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine [J].
Dresser, GK ;
Bailey, DG ;
Leake, BF ;
Schwarz, UI ;
Dawson, PA ;
Freeman, DJ ;
Kim, RB .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (01) :11-20
[10]   The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patients [J].
Malingré, MM ;
Schellens, JHM ;
Van Tellingen, O ;
Ouwehand, M ;
Bardelmeijer, HA ;
Rosing, H ;
Koopman, FJ ;
Jansen, SE ;
Schott, ME ;
Huinink, WWTB ;
Beijnen, JH .
BRITISH JOURNAL OF CANCER, 2001, 85 (10) :1472-1477